देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PROPENTOFYLLINE
INTERVET AUSTRALIA PTY LIMITED
propentofylline(50mg/Tb)
ORAL TABLET
PROPENTOFYLLINE ALKALOID Active 50.0 mg/Tb
#50 Tabs; #Bottle; 60 Tablets; Foil strip
VM - Veterinary Medicine
INTERVET AUSTRALIA
DOG - OLDER
CARDIOVASCULAR SYSTEM
ALLEVIATION OF DULLNESS, LETHARGY | LONGEVITY | FOR OLDER DOGS | OLD AGE | PROLONG LIFE
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG - OLDER: [ALLEVIATION OF DULLNESS, LETHARGY, LONGEVITY]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG - OLDER: [ALLEVIATION OF DULLNESS, LETHARGY, LONGEVITY]; For the alleviation of dullness, lethargy and improvement in overall demeanour in older dogs. May help in slowing development of hearing/sight defects associated with ageing and also slow the development of cataracts in aged animals.Contraindicated in pregnant or lactating bitches. Allergic skin reactions (e.g. urticaria) may occur rarely after administration.
Registered
2023-07-01
Registered Product Name; Pagelo f4 I Viv ilon i ~50 Pack Sizes ; 60 tablets Oate (Vers ion Control): ORAFT NZ Opt1on 1 111 1212009 AU reviewed 16112109 ACVM approved 01 April 2010 Warn ings removed 27 Ma 10 OeS~~i~tlOn; Carto n & Insert TeX T { ne ~ ; incorpo rati ng dose APVMA: Pend ing chan e and new ACVM Jabel sta lements Panel labels te xt above the header and below the fo ot er are not included In this labe l text. [INSERT] PRESCRIPTION ANIMAL REMEOY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY VIVITONIN@50 TABLETS FOR AGED DOGS Eac h film-coated tab let contains 50mg propentofy JJine. MODE OF ACT ION V ivito nin acts primarily by producing a m arked improvement in the m icro-ci rcu lat ion a nd the refore by increasing the oxygen supp ly in the per iphera l and cerebral ar eas . It may start to take effect afte r only a few days , de pend ing on the cl inica l sig ns . The clinical signs can be expected to retu rn once treatment has been dis continued. INDICAT IONS C ond it ions ass ociate d w ith the ageing process in dogs, such as let hargy, tiredness , . apathy , stiff ga it, difficu lty in stan di ng up and walking , lack of appetite , was ting , alopecia, d ull coat, when no specific ca use of th ese conditions can be fou nd, V ivito nin may hel p in slow ing the development of hearing and sight de fects assoc iated with agei ng and also slow the develop me nt of cataracts in aged anima ls. CONTRA INDICAT IONS Co ntraind icated in pregna nt or lactating bitches, as the compo und has not yet been eva luated for these anima ls . DOSAGE AND ADM INISTRATION 6 - 10 mg propentofylline/kg bodyweight dai ly divi ded into two doses give n am & pm as fo llows: Bodywei nht Tabl ets I Dailv Tota l ~ Da ily total Ka a.m D. m Ta ble ts (SOma l Dos e (mg/kal <5 kg Y. Y. II, 6.3 - 10.0 5 -8 kg II, II, 1 6.3 - 10.0 9- 15 kg 1 1 2 6.7 - 11.1 1 6- 25 kg 1 ~ 1 % 3 6.0 - g.4 26 -33k g 2 2 4 6.1 -7.7 34 -50 kg 3 3 6 6.0 - 8.8 The tab let can be adm inis ter ed directly onto the back of the tongue or can be mixed पूरा दस्तावेज़ पढ़ें
PRODUCT NAME: VIVITONIN® 50 & 100 TABLETS FOR AGED DOGS MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JULY, 2009 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Propentofylline is a xanthine derivative. TRADE NAME: VIVITONIN ® 50 & 100 TABLETS FOR AGED DOGS PRODUCT CODE: 176445, 176560 RECOMMENDED USE: For the alleviation of dullness, lethargy and improvement in overall demeanor in older dogs. Vivitonin widens blood vessels and makes blood less sticky, improving circulation. APVMA NO: 51394, 49892 CREATION DATE: November, 2006 THIS VERSION ISSUED: July, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: Ochre coloured tablets. ODOUR: No odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. INHALATION: SHORT TERM EXPOSURE: Long term inhalation of high amounts of any nuisance dust may overload lung clearance mechanism. Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. LONG TERM EXPOSURE: No data for health effects associated with long term ski पूरा दस्तावेज़ पढ़ें